Inside our section for professionals

KERN PHARMA Repaglinide tablets 17/10/11

KERN PHARMA, presents a new pharmaceutical product, Kern Pharma Repaglinide tablets distributed in tablets and is indicated in patients with type 2 diabetes whose hyperglycemia can not be controlled by diet, weight reduction and exercise. It is indicated in combination with metformin. The oral hypoglycemic should not be administered in patients with type 1 diabetes [...]

Read more...